Elliot et al., Cell, vol. 88, pp. 223-233 (Jan. 1997).* |
Barnett et al. Journal of General Virology, 73:2167-2171, 1992.* |
Sequence Database SPTREMBL, accession P89468, May 1997.* |
Bernstein et al., Vaccine 17:1681-1689, 1999. |
Elliott et al., “The Herpes Simplex Virus Type 1 Tegument Protein VP22 is Encoded by Gene UL49,” Journal of General Virology 73:723-726 (1992). |
Elliott et al., “V16 Interacts Via Its Activation Domain with VP22, a Tegument Protein of Herpes Simples Virus, and is Relocated to a Novel Macromolecular Assembly in Coexpressing Cells,” Journal of Virology 69(12):7932-7941(1995). |
Koelle et al., “Antigenic Specificities of Human CD4+ T-Cell Clones Recovered from Recurrent Genital Herpes Simplex Virus Type 2 Lesions,” Journal of Virology 68(5):2803-2810 (1994). |
Leslie et al., “Overexpression of the Herpes Simplex Virus Type 1 Tegument Protein VP22 Increases Its Incorporation Into Virus Particles,” Virology 220:60-68 (1996). |
McGeoch et al., “The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1,” J. Gen. Virol. 69:1531-1574 (1988). |
Meredith et al., “Post-Translational Modification of the Tegument Proteins (VP13 and VP14) of Herpes Simplex Virus Type 1 by Glycosylation and Phosphorylation,” Journal of General Virology 72:2771-2775 (1991). |
Spear et al., “Proteins Specified by Herpes Simplex Virus,” Journal of Virology 9(1):143-159 (1972). |
Muggeridge et al., “Herpes simplex virus” in Immunochemistry of viruses, II. The basis for serodiagnosis and vaccines. Eds. M.H.V. van Regenmortel and A.R. Neurath, 1990 Elsevier Science Publishers B.V. (Biomedical Division) 1990. |
Triezenberg et al., “Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression,” Genes & Development 2:718-729 (1998). |